| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
8,617.55
|
|
Change (%)
|
81.20 (0.95%)
|
|
Best Buy (RS)
|
8600.05(x2)
|
|
Best Sell (RS)
|
8618.8(x2)
|
|
Today's Range (RS)
|
8,431.65
-
8,644.85
|
|
52-Week Range (RS)
|
6,501.60
-
10,653.05
|
|
Beta (1 Year)
|
0.54
|
|
|
|
|
|
| Index Details |
| BSE 500, BSE HC, BSE SmallCap |
| News |
|
Corporate Details |
| Volumes jump at Timken India Ltd counter |
| AstraZeneca Pharma gets CDSCO nod for import and sale of Datverzo in India |
| AstraZeneca partners with Sun Pharma for second SZC brand in India |
| Astrazeneca Pharma and Sun Pharma form second brand partnership |
| AstraZeneca Pharma slides after Q2 PAT decline 2% QoQ |
| Astrazeneca Pharma India standalone net profit rises 41.09% in the September 2025 quarter |
| Astrazeneca Pharma India to discuss results |
| Astrazeneca Pharma India Ltd - Launch Of Sodium Zirconium Cyclosilicate Powder For Oral Suspension 5G (Lokelma) |
| AstraZeneca Pharma gets CDSCO nod for Enhertu |
| Astrazeneca Pharma India Ltd - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) ... |
|
|
|
| Incoporation Year : 1979 |
| Chairman : Shilpa Divekar Nirula |
| Ownership Group : MNC Associate |
| Sector : MAN |
| Industry : Pharmaceuticals - Multinational |
| Registered Office |
Astrazeneca Pharma India Ltd
Blk N1 12th Flr Manyata Embass,
Rachenahalli Outer Ring Road,
Bangalore,
Karnataka-560045 |
Phone:91-080-67748000
Fax:91-080-67748557 |
| E-Mail : comp.secy@astrazeneca.com |
| URL : http://www.astrazeneca.in |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
23-Jan-2026 |
8305.85 |
2.78 |
| 1Month |
30-Dec-2025 |
8904.60 |
-4.14 |
| 3Month |
30-Oct-2025 |
9461.85 |
-9.78 |
| 6Month |
30-Jul-2025 |
9291.00 |
-8.12 |
| 1Year |
30-Jan-2025 |
7266.10 |
17.48 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| Nippon India Small Cap Fund |
0.87 |
594.18 |
| Bandhan Large & Mid Cap Fund |
0.73 |
99.89 |
| Bandhan Innovation Fund |
3.82 |
75.81 |
| ICICI Pru Quality Fund |
2.48 |
57.50 |
| Nippon India Pharma Fund |
0.68 |
56.49 |
|
|
|
|
| Groups : Pharmaceuticals - Multinational |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Abbott India Ltd |
27,399.00 |
-1.00 |
35,921.55 |
25,611.00 |
58,809.38 |
| Glaxosmithkline Pharmaceuticals Ltd |
2,445.00 |
1.98 |
3,515.95 |
1,924.30 |
40,614.25 |
| Pfizer Ltd |
4,555.00 |
0.04 |
5,987.65 |
3,742.90 |
20,828.94 |
| Sanofi Consumer Healthcare India Ltd |
4,199.20 |
-1.65 |
5,954.00 |
3,967.00 |
9,833.27 |
| Sanofi India Ltd |
4,065.70 |
1.19 |
6,717.50 |
3,976.40 |
9,253.11 |
|
|
|
|